US20060018938A1 - Foam skin cream, use of the foam skin protection cream and a process of its preparation - Google Patents

Foam skin cream, use of the foam skin protection cream and a process of its preparation Download PDF

Info

Publication number
US20060018938A1
US20060018938A1 US11/180,913 US18091305A US2006018938A1 US 20060018938 A1 US20060018938 A1 US 20060018938A1 US 18091305 A US18091305 A US 18091305A US 2006018938 A1 US2006018938 A1 US 2006018938A1
Authority
US
United States
Prior art keywords
temperature
skin
weight
mixture
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/180,913
Inventor
Fritz Neubourg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neubourg Skin Care GmbH and Co KG
Original Assignee
Stephanie Neubourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to DE19735591 priority Critical
Priority to DE19735591.9 priority
Priority to PCT/EP1998/005232 priority patent/WO1999008649A2/en
Priority to US09/485,930 priority patent/US6423323B2/en
Priority to US10/196,726 priority patent/US20030059394A1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7839199&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20060018938(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stephanie Neubourg filed Critical Stephanie Neubourg
Priority to US11/180,913 priority patent/US20060018938A1/en
Publication of US20060018938A1 publication Critical patent/US20060018938A1/en
Assigned to NEUBOURG SKIN CARE GMBH & CO. KG reassignment NEUBOURG SKIN CARE GMBH & CO. KG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEUBOURG, STEPHANIE
Assigned to NEUBOURG SKIN CARE GMBH & CO. KG reassignment NEUBOURG SKIN CARE GMBH & CO. KG CORRECTIVE ASSIGNMENT TO CHANGE "ISSUED PATENT NUMBER" UNDER SECTION 4 FROM "6423434" TO -6423323--(PREVIOUSLY RECORDED AT R/F 019161/0303) Assignors: NEUBOURG, STEPHANIE
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/02Cosmetics or similar toilet preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/556Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/96Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toilet preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Abstract

A foam skin cream can be obtained by
  • preparing a phase I by melting at 75° C. a mixture containing fatty acids, especially C12-C22 fatty acids, optionally unsaturated and/or polyunsaturated fatty acids, emulsifiers, coemulsifiers, such as triceteareth-4-phosphate, followed by metering it with stirring to a phase II temperature-controlled at 75° C. obtained from an aqueous mixture containing moisturizers, such as propylene glycol and/or polyhydric alcohols, especially glycerol, emulsifiers, such as alkyl sarcosinates, and skin care additives, such as allantoin; wherein homogeneous mixing of phases I and II is provided and said metering is performed at a temperature of 75° C.; after the metered addition, the temperature is maintained at 75° C. for a period of between 5 and 20 minutes; whereupon the temperature of the thus obtained mixture is lowered to a temperature of between 30 and 40° C. with constant stirring; the pH value is adjusted to from 7.6 to 8.2, preferably with a skin-compatible basic organic compound, and the mixture obtained is filled into dosage forms with the addition of a propellant.

Description

  • The present invention relates to a foam skin cream, uses of the foam skin protection cream and a process for its preparation.
  • The galenic principle of an emulsoid two-phase system having lipophilic or hydrophobic components and, on the other hand, hydrophilic components has been known for the production of foam preparations for skin care. The application of these foam preparations to the treated skin forms a two-dimensional two-phase network, the hydrophilic components bind to the keratin of the horny layer and enable the evaporation of sweat while the lipophilic components inhibit the permeation of moisture (including the penetrated sweat) on the skin surface. As the foam, in contrast to other creams building a barrier, is absorbed in less than a minute, does not leave any grease traces on the working materials and prevents heat built-up or even maceration effects from the action of sweat, the foam has enjoyed rapidly growing popularity as a protective agent against occupational action of moisture. Further details about the per se known foam skin creams can be seen, in particular, from “Haut”, issue 4, 1992, by R. Rudolph, L. Bade, B. Brüggemann.
  • In “hautnah derm” 10 (1994), 344-351, B. Kunze reports lipid-containing skin protection foams which are indicated for dry sensitive skin and chronical-rhagadiform eczemas. Ingredients are also disclosed therein. The skin protection foams described therein are protective against a lot of occupational noxious matters, such as acid permanent waving liquids in the hairdresser's trade, lyes, oils, disinfectants, cleaning and rinsing agents, but also against water, moisture, sweat, feces, urine and mineral dusts.
  • EP 0 598 412 also relates to skin protection foams; PTFE is described as an active principle.
  • DE-C-33 30 628 relates to skin protection and care-lotions containing silicone oils, partially neutralized stearic acid, fatty alcohols and their ethoxylated derivatives, ethoxylated wool alcohols, cetyl/stearyl alcohol, vaseline, thickeners and water. The lotions disclosed therein are said to be quickly absorbed without leaving an annoying grease film on the skin for extended periods of time.
  • Information about emulsifiers which can be employed in skin care agents are found in DE-A-195 42 572. This reference suggests emulsifiers which contain from 43 to 90% by weight of alkyl and/or alkenyl oligoglycosides and from 10 to 57% by weight of fatty alcohols. These emulsifiers are particularly suitable for the preparation of highly viscous, sensorily light oil-in-water emulsions having a long shelf life. The German utility model DE-U-9308050 relates to a skin protection foam used against skin-aggressive agents. This foam consists of an aqueous emulsion containing fatty acid esters with good skin compatibility for the production of a moisture-permeable film, polyhydric alcohol for stably dispersing the active agents and controlling the humidity of the film, emulsifiers for improving foam stability, surfactants for reducing the surface tension and optionally neutralizing agents for resins and emulsifiers. Gaseous hydrocarbons may be used as propellants, for example, propane, butane or isobutane and mixtures thereof. However, the foams described do not contain any free fatty acids.
  • Aerosoles are complicated physical-chemical structures which do not form under arbitrary circumstances. In Particular, a special balance between the foam-forming components is important. Slight shifts in the composition may already result in a collapse of the foam; thus, a formulation of per se active substances may not be capable of being formulated as a foam without further provisions.
  • Especially in occupational applications, skin creams are often found unpleasant because the “fatting” components remain too long on the skin and lead to annoying finger traces or generally to an unpleasant feeling. This has been remedied to some extent by the per se known skin foams since they help preventing or reducing overload of the skin with the fatting matters. Nevertheless, it is desirable to find even more acceptance by the user, especially in the long-term use of skin protection agents.
  • It has been the object of the present invention to extend the application range of skin protection foams by providing a formulation which is highly accepted by the user, the admixture of a wide variety of other substances being allowed without destroying the aerosol employed or deteriorating the properties of the aerosol.
  • The object of the invention is surprisingly achieved by a base formulation of a foam skin cream having the features of claim 1. Dependent claims 2 to 12 relate to preferred embodiments of the foam skin cream according to the invention. Claims 13 to 16 relate to uses of the foam skin cream according to the invention, whereas claim 17 relates to a process for preparing the base of a foam skin cream according to the invention.
  • The foam skin cream according to the invention can be obtained by
    • preparing a phase I by melting at 75° C. a mixture containing fatty acids, especially C12-C22 fatty acids, optionally unsaturated and/or polyunsaturated fatty acids, emulsifiers, coemulsifiers, such as triceteareth-4-phosphate, followed by metering it with stirring to
    • a phase II temperature-controlled at 75° C. obtained from an aqueous mixture containing moisturizers, such as propylene glycol and/or polyhydric alcohols, especially glycerol, emulsifiers, such as alkyl sarcosinates, and skin care additives, such as allantoin;
    • wherein homogeneous mixing of phases I and II is provided and said metering is performed at a temperature of 75° C.;
    • after the metered addition, the temperature is maintained at 75° C. for a period of between 5 and 20 minutes; whereupon the temperature of the thus obtained mixture is lowered to a temperature of between 30 and 40° C. with constant stirring;
    • the pH value is adjusted to from 7.6 to 8.2, preferably with a skin-compatible basic organic compound, and the mixture obtained is filled into dosage forms with the addition of a propellant.
  • At the one hand, the product obtainable according to this process can be directly employed as a foam skin cream in the industrial field for the protection from or reduction of the absorption of cancerogenic substances, such as polycyclic aromatic hydrocarbons. This mixture is capable of providing effective protection for persons whose skin has already been exposed to cancerogenic substances, such as polycyclic aromatic hydrocarbons. In addition, the mixture is suitable for providing protection to persons from the action of acids, lyes (not above pH 11), scouring agents and detergents, sweat, urine, stool, rubber gloves, dusts, house dust, machine, drilling and cooling oils, greases, paints/varnishes, gypsum and other substances and chemicals, especially aggressive substances and chemicals.
  • The foam skin cream according to the invention contains fatty acids, especially C12-C22 fatty acids, and may optionally additionally contain unsaturated and/or polyunsaturated fatty acids. Useful fatty acids which are saturated include, in particular, the naturally occurring C12-C22 fatty acids, especially stearic acid and palmitic acid. Myristic acid may also be used. Useful unsaturated fatty acids include, in particular, those having up to three unsaturated bonds in their hydrocarbon chain. Unsaturated fatty acids are found, for example, in fractions of coconut fat. Useful coemulsifiers include per se known coemulsifiers, especially triceteareth-4-phosphate, sodium laureth-4-phosphate or oleth-3 and other lipophilic emulsifiers based on fatty alcohols with a low degree of ethoxylation.
  • Phase I may additionally contain paraffinum liquidum. Emulsifiers to be used in phase I may include those based on fatty alcohols and those based on partial esters of fatty acids. Particularly preferred fatty alcohols include cetearyl alcohol. Glyceryl stearate, for example, may be employed as a partial ester of a fatty acid.
  • The moisturizers to be used in phase II include, in particular, propylene glycol and/or polyhydric alcohols, such as glycerol. As particular emulsifiers to be used in phase II, there may be mentioned alkyl sarcosinates, such as lauroyl, lauryl, cetyl sarcosinates.
  • The mixture obtainable according to claim 1 also serves as a base for other foam skin creams which may be employed in a wide range of applications for protecting the skin and alleviating dermatological dysfunctions.
  • If desired, one or more preservatives may be added to the foam skin cream according to the invention. In particular, substances such as methyldibromoglutaronitrile and/or phenoxyethanol have proven to be suitable preservatives. These substances may be added in amounts of from 0.01 to 1% by weight.
  • Preferably, the emulsifiers, fatty acids, coemulsifiers, moisturizers and skin care agents, especially allantoin, panthenol etc., are used in the following amounts:
    • from 4 to 15% by weight of oil-in-water emulsifier;
    • from 1 to 10% by weight of fatty acid, especially from 4 to 7% by weight, preferably from 4.5 to 6% by weight;
    • from 0.4 to 2.3% by weight of coemulsifier;
    • from 1 to 10% by weight of moisturizer;
    • from 0.05 to 1% by weight of skin care agent; and
    • water as the balance to make 100% by weight.
  • A preferable foam skin cream according to the invention contains:
    • from 1 to 3% by weight of glyceryl stearate;
    • from 3 to 6% by weight of cetearyl alcohol;
    • from 4 to 6% by weight of stearic acid;
    • from 0.5 to 2% by weight of paraffin;
    • from 0.4 to 2.3% by weight of triceteareth-4-phosphate;
    • from 1.5 to 4% by weight of propylene glycol;
    • from 1.3 to 4.2% by weight of glycerol;
    • from 1 to 3% by weight of cetyl sarcosinate;
    • from 0.05 to 1% by weight of allantoin; and
    • water as the balance to make 100% by weight.
  • In another preferred embodiment, the foam skin cream according to the invention additionally contains a silicone-containing substance, such as dimethicone. This substance is added to phase I. Preferably, it is present in amounts of from 0.05 to 1% by weight.
  • In addition, the foam skin cream according to the invention may additionally contain one or more refatting substances in phase I, such as decyl oleate, isohexadecane, stearic acid glycol ester, coconut fatty acid ethanolamide, corn oil, peanut oil, almond oil, sesame oil, olive oil, jojoba oil, soybean oil, wool wax alcohols, paraffin, medium-chain triglycerides, oleic acid oleyl esters, white petrolatum, macrogol-glycerol hydroxystearate, hydrogenated castor oil, castor oil from Ricinus communis, avocado oil, wheat germ oil, palmitic acid isopropyl ester, cetyl palmitate, myristic acid myristyl ester and/or octyldodecanol.
  • In particular, the foam skin cream contains amounts of from 0.5 to 2% by weight of decyl oleate and/or from 0.5 to 2% by weight of octyldecanol, or another of the refatting substances mentioned, if the product is to be used for normal skin. The total amount of refatting substances is to be such that the skin protection foam is not destroyed. An amount of about 4% by weight of refatting substances is sufficient for normal to slightly dry skin. If dry skin is to be treated with the foam skin cream according to the invention, amounts of from 3 to 6% by weight of a component of the refatting substances, such as, in particular, decyl oleate and/or octyldecanol, are recommendable. If more than one component is used, the total amount of refatting components is to be about 12% at most for slightly dry skin. If even more severely dry skin is treated, the amount of refatting substances is from about 6 to 9% by weight if a component such as decyl oleate is used, and from 6 to 9% by weight if octyldecanol is used. The amount of refatting substance may then be up to 20% by weight.
  • Like the products without silicone-containing substances, the latter foam skin creams are suitable for the care and protection of the skin, especially from aggressive substances, such as scouring agents and detergents, sweat, urine, stool, rubber gloves, dusts, house dust, machine, drilling and cooling oils, greases, paints/varnishes, gypsum and other substances and chemicals, especially aggressive substances and chemicals.
  • The foam skin creams are also suitable for the treatment or alleviation of dermatological diseases. This includes, in particular, dermatological diseases such as allergic contact dermatitis type I and IV, cumulative-subtoxic eczema, toxic-irritative eczema, microbial-dysregulative eczema, atopic dermatitis, atopic palmoplantar eczema, dyshidrosis, hyperhidrosis, contact urticaria, intertriginous eczema in connection with hemorrhoids, various weeping fungal infections, e.g., interdigital mycosis, perleches, psoriasis vulgaris, ulcus cruris, cholinergic urticaria, diaper dermatitis.
  • It may be indicated to include substances which can increase the moisture content of the skin, in addition to refatting substances. Such hydratizing substances include, in particular, urea, ethoxydiglycol, sodium chloride, magnesium chloride, sorbitol, dexpanthenol, sodium lactate, allantoin, hyaluronic acid, vitamin E, linolenic acid. The amount of those substances can be from 1 to 20% by weight or more of the respective substances, depending on the severity of the disease to be treated. These quantities also apply, in particular, to urea which may also be present in amounts of from 3 to 15% by weight or from 12.5 to 15% by weight. The foam skin cream according to the invention may also be used for psoriasis.
  • One particularly important field of application concerns the prophylaxis and treatment of diabetic foot. Due to accompanying symptoms of diabetes, diabetics suffer from dry skin which in the course of the diseases favors damage to the extremities, up to an extent where amputation becomes necessary in the case of those having been diabetic for many years. Prophylactic application of skin protection agents which provide an improvement of the skin parameters in diabetics can prevent the development of diabetic foot.
  • In addition, skin care substances, such as polyunsaturated fatty acids (PUFA), may be added to the foam skin cream according to the invention. These include, in particular, omega-6 fatty acids as known, for example, from evening primrose oil and borage oil. Both synthetic omega-6 fatty acids and those obtained from the mentioned plant extracts may be employed.
  • Further, there may be used soothing substances, such as chamomile extract, as another fraction which may be admixed with the foam skin cream according to the invention.
  • Skin-active vitamins, such as vitamins A, E and F, may be admixed with the foam skin cream according to the invention in effective amounts. Especially for the treatment and prevention of diaper dermatitis, admixing the following substances has proven useful: from 3 to 7% by weight of Calendula extract, from 3 to 7% by weight of Hamamelis extract, from 3 to 7% by weight of chamomile extract, from 3 to 7% by weight of tea tree oil extract, from 1 to 5% by weight of decyl oleate, from 1 to 5% by weight of octyldodecanol.
  • The process according to the invention for the preparation of the foam skin protection cream according to the invention comprises the following steps:
    • preparing a phase I by melting at 75° C. a mixture containing fatty acids, especially C12-C22 fatty acids, optionally unsaturated and/or polyunsaturated fatty acids, coemulsifiers, such as triceteareth-4-phosphate, followed by metering this phase with stirring to
    • a phase II molten at 75° C. obtained from an aqueous mixture containing moisturizers, such as propylene glycol and/or polyhydric alcohols, especially glycerol, emulsifiers, such as alkyl sarcosinates, and skin care additives, such as allantoin;
    • wherein homogeneous mixing of phases I and II is provided and said metering is performed at a temperature of 75° C.;
    • after the addition of phase I to phase II, the temperature is maintained at 75° C. for a period of between 5 and 20 minutes; whereupon the temperature of the thus obtained mixture is lowered to a temperature of between 30 and 40° C. with constant stirring;
    • adjusting the pH value to from 7.6 to 8.2, preferably with a skin-compatible basic organic compound, and filling into containers with the addition of a propellant.
  • The invention will be further illustrated by the following Example.
  • EXAMPLE
  • The skin protection cream according to the invention is prepared in a heatable and coolable closed apparatus with a self-withdrawing homogenisator and a heatable metering funnel (preferably in a Koruma multipurpose apparatus).
  • The preparation of phase I is effected in a heatable metering funnel by melting at 75° C. a mixture containing 2% by weight of glyceryl stearate, 4% by weight of cetearyl alcohol, 5% by weight of stearic acid, 1% by weight of paraffin and 1% by weight of triceteareth-4-phosphate, followed by metering this phase with stirring to phase II previously prepared in the heatable and coolable closed apparatus with a self-withdrawing homogenisator. Phase II consists of an aqueous mixture containing 2.5% by weight of propylene glycol, 2.5% by weight of glycerol, 2% by weight of sodium lauroylsarcosinate and 0.3% by weight of allantoin. The amount of water is 79.7% by weight. Homogeneous mixing of phases I and II is to be provided.
  • The metering of phase I is performed at a temperature of 75° C. Both phases are combined with constant stirring at a medium stirring speed, and care must be taken that homogenization is effected uniformly. The temperature is maintained at 75° C. for between 5 and 20 min. The mixture obtained is cooled to a temperature of between 30 and 40° C. with constant stirring.
  • Then, after a temperature of 40° C. has been reached, the further substances may be added. This may include adjusting the pH value to between 7.8 and 8.0. For this purpose, 2-amino-2-methyl-1-propanol is used. Stirring is continued for a sufficient period of time until the pH value has stabilized, followed by filling into suitable storage tanks or into the corresponding spraying containers. In the latter case, 91% of drug is filled together with 9% of butane/propane.

Claims (12)

1-17. (canceled)
18. A foam aerosol skin cream, wherein the skin cream does not contain PTFE, obtained by
preparing a phase I by melting at 75° C. a mixture containing one or more C10-C22 fatty acids, optionally containing an unsaturated or polyunsaturated fatty acid, an emulsifier, or a coemulsifier or a mixture thereof;
preparing a phase II, temperature-controlled at 75° C., by aqueous admixture of urea, as a moisture-binding agent, and two or three ingredients selected from the group consisting of a moisturizer, an emulsifier, and a skin care additive, and a combination thereof;
metered addition with homogenous mixing of phase I and phase II at a temperature of 75° C.; followed by
maintaining the temperature of the homogeneous mixture at 75° C. for a period of between 5 and 20 minutes; followed by
lowering the temperature of the homogeneous mixture from 75° C. to a temperature between 30° C. and 40° C. with constant stirring; followed by
adjusting the pH of the homogeneous mixture at a temperature between 30° C. and 40° C. to a value of 7.6 to 8.2; followed by
combining the homogeneous mixture with a propellant in a dosage form, wherein the propellant is butane, propane, or a mixture thereof.
19. The foam aerosol skin cream according to claim 18, wherein phase I further contains as a coemulsifier triceteareth-4-phosphate.
20. The foam aerosol skin cream according to claim 18, wherein the moisturizer in phase II is propylene glycol, a polyhydric alcohol, or a combination thereof.
21. The foam aerosol skin cream according to claim 18, wherein the moisturizer in phase II is glycerol and the emulsifier in phase II is an alkyl sarcosinate.
22. The foam aerosol skin cream according to claim 18, wherein the skin care additive in phase II is allantoin.
23. The foam aerosol skin cream according to claim 18, wherein the pH is adjusted to a value from of 7.6 to 8.2 by adding a skin-compatible basic organic compound.
24. The foam aerosol skin cream according to claim 18, further comprising adding a preservative to the homogeneous mixture, with stirring, at the temperature of 30° C. to 40° C.
25. The foam aerosol skin cream according to claim 18, containing
from 4 to 15% by weight of oil-in-water emulsifier;
from 1 to 10% by weight of the C10-C22 fatty acid;
from 0.4 to 2.3% by weight of the coemulsifier;
from 1 to 20% urea;
from 1 to 10% by weight of the moisturizer;
from 0.5 to 1% by weight of the skin care additive; and
water as the balance to make 100% by weight.
26. A process for making the foam aerosol skin cream comprising:
preparing a phase I by melting at 75° C. a mixture containing one or more C10-C22 fatty acids, optionally containing an unsaturated or polyunsaturated fatty acid, an emulsifier, or a coemulsifier or a mixture thereof;
preparing a phase II, temperature-controlled at 75° C., by aqueous admixture of urea, as a moisture-binding agent, and two or three ingredients selected from the group consisting of a moisturizer, an emulsifier, and a skin care additive, and a combination thereof;
metered addition with homogenous mixing of phase I and phase II at a temperature of 75° C.; followed by
maintaining the temperature of the homogeneous mixture at 75° C. for a period of between 5 and 20 minutes; followed by
lowering the temperature of the homogeneous mixture from 75° C. to a temperature between 30° C. and 40° C. with constant stirring; followed by
adjusting the pH of the homogeneous mixture at a temperature between 30° C. and 40° C. to a value of 7.6 to 8.2.
27. The foam aerosol skin cream made by the process according to claim 26.
28. A process of making a container of spray foam aerosol cream comprising filling the foam aerosol cream of claim 27 together with a propellant into a spray-can container, wherein the propellant is butane, propane, or a mixture thereof.
US11/180,913 1997-08-18 2005-07-14 Foam skin cream, use of the foam skin protection cream and a process of its preparation Abandoned US20060018938A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE19735591 1997-08-18
DE19735591.9 1997-08-18
PCT/EP1998/005232 WO1999008649A2 (en) 1997-08-18 1998-08-18 Foaming skin cream
US09/485,930 US6423323B2 (en) 1997-08-18 1998-08-18 Foam skin cream, uses of the foam skin protection cream and a process for its preparation
US10/196,726 US20030059394A1 (en) 1997-08-18 2002-07-17 Foam skin cream, uses of the foam skin protection cream and a process for its preparation
US11/180,913 US20060018938A1 (en) 1997-08-18 2005-07-14 Foam skin cream, use of the foam skin protection cream and a process of its preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/180,913 US20060018938A1 (en) 1997-08-18 2005-07-14 Foam skin cream, use of the foam skin protection cream and a process of its preparation
US12/000,314 US20080213193A1 (en) 1997-08-18 2007-12-11 Foam skin cream, uses of the foam skin protection cream and a process for its preparation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/196,726 Continuation US20030059394A1 (en) 1997-08-18 2002-07-17 Foam skin cream, uses of the foam skin protection cream and a process for its preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/000,314 Continuation US20080213193A1 (en) 1997-08-18 2007-12-11 Foam skin cream, uses of the foam skin protection cream and a process for its preparation

Publications (1)

Publication Number Publication Date
US20060018938A1 true US20060018938A1 (en) 2006-01-26

Family

ID=7839199

Family Applications (4)

Application Number Title Priority Date Filing Date
US09/485,930 Expired - Lifetime US6423323B2 (en) 1997-08-18 1998-08-18 Foam skin cream, uses of the foam skin protection cream and a process for its preparation
US10/196,726 Abandoned US20030059394A1 (en) 1997-08-18 2002-07-17 Foam skin cream, uses of the foam skin protection cream and a process for its preparation
US11/180,913 Abandoned US20060018938A1 (en) 1997-08-18 2005-07-14 Foam skin cream, use of the foam skin protection cream and a process of its preparation
US12/000,314 Abandoned US20080213193A1 (en) 1997-08-18 2007-12-11 Foam skin cream, uses of the foam skin protection cream and a process for its preparation

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/485,930 Expired - Lifetime US6423323B2 (en) 1997-08-18 1998-08-18 Foam skin cream, uses of the foam skin protection cream and a process for its preparation
US10/196,726 Abandoned US20030059394A1 (en) 1997-08-18 2002-07-17 Foam skin cream, uses of the foam skin protection cream and a process for its preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/000,314 Abandoned US20080213193A1 (en) 1997-08-18 2007-12-11 Foam skin cream, uses of the foam skin protection cream and a process for its preparation

Country Status (10)

Country Link
US (4) US6423323B2 (en)
EP (1) EP1014916B2 (en)
JP (1) JP4057234B2 (en)
AT (1) AT210954T (en)
AU (1) AU9162498A (en)
CA (1) CA2300054C (en)
DK (1) DK1014916T4 (en)
ES (1) ES2170522T5 (en)
PT (1) PT1014916E (en)
WO (1) WO1999008649A2 (en)

Cited By (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265240A1 (en) * 2003-04-28 2004-12-30 Foamix Ltd. Foamable iodine composition
US20050031547A1 (en) * 2003-08-04 2005-02-10 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050069566A1 (en) * 2003-08-04 2005-03-31 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US20050075407A1 (en) * 2003-08-25 2005-04-07 Foamix Ltd. Foam incorporating eutetic mixture
US20050074414A1 (en) * 2002-10-25 2005-04-07 Foamix Ltd. Penetrating pharmaceutical foam
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20050232869A1 (en) * 2002-10-25 2005-10-20 Foamix Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20050244342A1 (en) * 2002-10-25 2005-11-03 Foamix Ltd. Moisturizing foam containing lanolin
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20050271598A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Body cavity foams
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20060269485A1 (en) * 2002-11-29 2006-11-30 Foamix Ltd. Antibiotic kit and composition and uses thereof
US20060275221A1 (en) * 2005-05-09 2006-12-07 Foamix Ltd. Saccharide foamable compositions
US20070020213A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20070020304A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20070098647A1 (en) * 2005-09-28 2007-05-03 Neubourg Skin Care Gmbh & Co. Kg Skin care products
US20070253911A1 (en) * 2002-10-25 2007-11-01 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080044444A1 (en) * 2002-10-25 2008-02-21 Foamix Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20080166303A1 (en) * 2006-09-08 2008-07-10 Dov Tamarkin Colored or colorable foamable composition and foam
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080253973A1 (en) * 2002-10-25 2008-10-16 Foamix Ltd. Sensation modifying topical composition foam
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080267890A1 (en) * 2005-01-20 2008-10-30 Kayban Pty Ltd. Anti-Microbial Agent
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US20080299220A1 (en) * 2003-08-04 2008-12-04 Dov Tamarkin Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20100310476A1 (en) * 2007-12-07 2010-12-09 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9162498A (en) * 1997-08-18 1999-03-08 Neubourg, Stephanie Foaming skin cream, uses thereof and a method for producing the same
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6627178B1 (en) * 1999-07-30 2003-09-30 Garret D. Cawthon Methods, compositions and systems for the prevention and treatment of diaper rash
FR2807321B1 (en) * 2000-04-06 2002-08-30 Seppic Sa New asset, composition containing it and use in cosmetic, dermocosmetic, dermopharmaceutical or pharmaceuticals or of woven materials or nonwoven
FR2817769B1 (en) * 2000-12-08 2003-09-12 Hospal Ind An apparatus for the extracorporeal treatment of blood or plasma comprising a wet semipermeable membrane and processes for producing
DE10063342A1 (en) * 2000-12-19 2002-06-20 Beiersdorf Ag Cosmetic or dermatological composition contains three-part emulsifier system and gas
DE10063341A1 (en) * 2000-12-19 2002-06-20 Beiersdorf Ag Cosmetic or dermatological composition contains three-part emulsifier system, lipid phase and gas
DE10063340A1 (en) * 2000-12-19 2002-08-29 Beiersdorf Ag Self-foaming or foam-like preparations
JP2002265347A (en) * 2001-03-13 2002-09-18 Shiseido Co Ltd Cosmetic promoting maturation of cornified envelope
DE10113046A1 (en) * 2001-03-15 2002-09-26 Beiersdorf Ag Self-foaming product for dermatological and cosmetic products comprises an emulsifier system, a lipid phase, gas, organic hydrocolloid and a solid body
DE10113050A1 (en) * 2001-03-15 2002-09-19 Beiersdorf Ag Self-foaming or foamed cosmetic or dermatological composition comprises a specified emulsifier system, a lipid phase, a gas and an organic hydrocolloid
DE10134786A1 (en) * 2001-07-17 2003-02-06 Beiersdorf Ag foamable preparations
DE10144061A1 (en) * 2001-09-07 2003-04-17 Beiersdorf Ag hydrophobized self-foaming or foam-like preparations with inorganic gel-forming agents, organic hydrocolloids and particulate hydrophobic and / or and / or oil-absorbing solid-body substances
DE10147820A1 (en) * 2001-09-27 2003-04-10 Beiersdorf Ag Self-foaming, foam-like, after-foaming or foamable cosmetic or dermatological preparations with a content of waxes or solid at room temperature and / or semi-solid lipids
DE10155956A1 (en) * 2001-11-09 2003-05-22 Beiersdorf Ag Self-foaming, foam-like, after-foaming or foamable cosmetic or dermatological preparations
DE10155792A1 (en) * 2001-11-14 2003-05-22 Beiersdorf Ag Self-foaming, foam-like, after-foaming or foamable cosmetic or dermatological preparations with a content of siloxane elastomers
US20030170282A1 (en) * 2002-03-05 2003-09-11 Walz David K. Method of skin protection during hair treatment
US8053626B2 (en) 2002-06-12 2011-11-08 Sca Hygiene Products Ab Absorbent article containing a skincare composition and method of making and using same
DE10228229A1 (en) * 2002-06-25 2004-03-18 Beiersdorf Ag foamable preparations
US7544674B2 (en) * 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
DE10250755B4 (en) * 2002-10-31 2007-02-08 Merz Pharma Gmbh & Co. Kgaa A foamable composition based on an O / W emulsion with a combination of a silicone-based emulsifier and an anionic surfactant with improved skin effect, their preparation and their use
AU2003293865A1 (en) * 2002-12-12 2004-06-30 Allpresan Gesellschaft Zum Vertrieb Von Gesundheitsprodukten Fur Allergiker Mbh Stable foam cream
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US20070140999A1 (en) * 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US7169401B2 (en) * 2003-07-18 2007-01-30 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
DE10347824B4 (en) * 2003-10-10 2011-08-11 Lach, Hans-Joachim, Dr., 79331 Pharmaceutical or cosmetic composition for treating the skin
AU2003274610A1 (en) * 2003-11-05 2005-05-26 Medena Ag Foamed skin cream
DE10356164A1 (en) * 2003-12-02 2005-08-04 Beiersdorf Ag Active ingredient combinations of licochalcone A or an extract from Radix Clycyrrhizae inflatae containing licochalcone A, phenoxyethanol, and, if desired, glycerol
EP1649846A1 (en) * 2004-10-21 2006-04-26 Neubourg Skin Care GmbH & Co. KG Use of urea for the treatment of age spots
US8431165B2 (en) * 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
NZ563560A (en) 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
ES2393761T3 (en) * 2006-07-14 2012-12-27 Stiefel Research Australia Pty Ltd pharmaceutical foam fatty acid
US7801502B2 (en) * 2006-12-18 2010-09-21 Aai Corporation Method for implementing continuous radio frequency (RF) alignment in advanced electronic warfare (EW) signal stimulation systems
DE102008020797A1 (en) 2008-04-22 2009-10-29 Aquyo Cosmetics Gmbh Skin cream useful for e.g. treatment and/or prophylaxis of dry skin and/or skin damage in diabetic foot, comprises saccharide e.g. mannobiose, polysaccharide e.g. dextran, multivalent alcohol e.g. glycerol, urea, polycation and carrier
US8895080B2 (en) 2008-06-20 2014-11-25 Ocusoft, Inc. Compositions and kits for ocular treatment
US20090317503A1 (en) * 2008-06-20 2009-12-24 Ocusoft, Inc. Eyelid Preparation and Method of Use
CA2646932A1 (en) * 2008-12-10 2010-06-10 Lancelot Biotech Inc. Method for the topical application of a medicinal preparation
ES2364692T3 (en) * 2008-12-23 2011-09-12 Intendis Gmbh foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin.
ES2537151T3 (en) 2009-12-10 2015-06-02 Neubourg Skin Care Gmbh & Co. Kg Foam formulations stabilized with polymers, free of emulsifiers
US8409628B2 (en) * 2010-02-04 2013-04-02 Penguin IP Holdings, Inc. Methods and compositions for oxygenation of skin to treat skin disorders
EP2371350B1 (en) 2010-03-04 2013-04-24 Neubourg Skin Care GmbH & Co. KG Foam formulas for treating animal skin illnesses
US8900601B2 (en) 2010-03-31 2014-12-02 Jennifer Bartels Permeable mixtures, methods and compositions for the skin
DE102011018924A1 (en) 2011-04-28 2012-10-31 Tunap Industrie Chemie Gmbh & Co. Produktions Kg OW-emulsion concentrate, a process for its production, and this skin cosmetic containing
US9913870B2 (en) * 2012-01-13 2018-03-13 Dharma Biomedical, Llc Method for stimulating AMP-activated protein kinase
US9717679B1 (en) 2012-12-17 2017-08-01 Touchless Designs LLC Methods for the prevention and treatment of animal skin conditions
US9539275B2 (en) * 2014-01-27 2017-01-10 Hong Kong Baptist University Melanogenesis effect of saponins of gynostemma pentaphyllum
US10258646B2 (en) * 2014-10-28 2019-04-16 Andrea Rosanoff Cream transdermal magnesium supplement
DE102015221568A1 (en) 2015-11-04 2017-05-04 Beiersdorf Ag Cosmetic foam of an emulsion containing glycerol and alcohol
DE102015221565A1 (en) 2015-11-04 2017-05-04 Beiersdorf Ag Cosmetic foam of an emulsion containing glyceryl stearate citrate
DE102015221566A1 (en) 2015-11-04 2017-05-04 Beiersdorf Ag Cosmetic foam of an emulsion containing glyceryl monostearate and sodium cetearyl sulfate
DE102015221567A1 (en) 2015-11-04 2017-05-04 Beiersdorf Ag Cosmetic foam of an emulsion containing betaine
EP3468530A1 (en) 2016-06-10 2019-04-17 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
DE102016223502A1 (en) 2016-11-28 2018-05-30 Beiersdorf Ag UV filters containing, Cosmetic foam of an emulsion containing glyceryl monostearate and sodium cetearyl sulfate
DE102016224029A1 (en) 2016-12-02 2018-06-07 Beiersdorf Ag Foaming cleansing preparation emulsion-based-1

Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3666863A (en) * 1968-03-06 1972-05-30 Medisan Ab Skin-treating composition and vehicle for skin-treating agents
US3970584A (en) * 1973-02-14 1976-07-20 S. C. Johnson & Son, Inc. Aerosol package containing a foam-forming emulsion and propellent system
US4137302A (en) * 1976-04-02 1979-01-30 Lever Brothers Company Cosmetic composition
US4145411A (en) * 1974-09-05 1979-03-20 Colgate-Palmolive Company Pressurized foaming shaving composition
US4459285A (en) * 1981-02-27 1984-07-10 Societe Anonyme Dite: L'oreal Cosmetic composition for the treatment of the hair and skin comprising a powder of flowers or flower tops and a cohesion agent
US4661340A (en) * 1983-06-06 1987-04-28 Interkemia Vegyipari Gazdasagi Tarsasag Quail egg based stabilized foam compositions for cosmetic purposes
US5000938A (en) * 1988-08-12 1991-03-19 Innovatec S.A. Protective aerated foam hand lotion and process for preparing the same
US5086903A (en) * 1991-04-08 1992-02-11 Interrolll Holding Ag Tandem brake roller system
US5139781A (en) * 1990-02-13 1992-08-18 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Topical composition comprising mono- and di-alkyl or alkenyl phosphates and alkylamidopropyl betaines of alkylamphoglycinates
US5278263A (en) * 1992-10-05 1994-01-11 The Goodyear Tire & Rubber Company Syndiotactic 1,2-polybutadiene synthesis in an aqueous medium utilizing N,N-dibutylformamide as a modifier
US5334387A (en) * 1993-02-23 1994-08-02 Colgate-Palmolive Company Topical composition comprising mono and dialkyl phosphates with a cosurfactant
US5439682A (en) * 1991-11-22 1995-08-08 Richardson-Vicks Inc. Combined personal cleansing and moisturizing compositions
US5472686A (en) * 1990-12-28 1995-12-05 Nippon Unicar Company Limited Cosmetic formulations
US5500211A (en) * 1994-09-22 1996-03-19 The Gillette Company Soap-free self-foaming shave gel composition
US5525588A (en) * 1994-09-14 1996-06-11 Elzabeth Arden Co. Cosmetic composition
US5621012A (en) * 1994-06-14 1997-04-15 Beiersdorf Aktiengesellschaft Active compound combinations having a content of glyceryl alkyl ethers and cosmetic and dermatological formulations comprising such active compound combinations
US5674511A (en) * 1994-12-06 1997-10-07 The Procter & Gamble Company Shelf stable skin cleansing liquid with gel forming polymer, lipid and crystalline ethylene glycol fatty acid ester
US5788972A (en) * 1994-10-24 1998-08-04 L'oreal Product for topical application containing a lipase and an active ingredient precursor
US5882659A (en) * 1995-12-01 1999-03-16 L'oreal Use of a polyholoside in a cleaning or make-up-removing composition and composition comprising same
US5902590A (en) * 1994-03-03 1999-05-11 Henkel Kommanditgesellschaft Auf Aktien Cosmetic and/or pharmaceutical formulations
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551480A (en) * 1983-06-21 1985-11-05 Stiefel Laboratories, Inc. Compositions for the treatment of psoriasis
DE3330628C2 (en) * 1983-08-25 1985-11-07 Schuelke & Mayr Gmbh, 2000 Norderstedt, De
DE3670569D1 (en) 1985-03-01 1990-05-31 Procter & Gamble Mild cleansing foam.
US5002680A (en) * 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
DE3628531C2 (en) 1986-08-22 1988-12-15 Merz + Co Gmbh & Co, 6000 Frankfurt, De
US5277336A (en) * 1990-12-31 1994-01-11 L'oreal Device for the pressurized dispensing of a product, especially a foaming product, and processes for filling a container for a device of this kind
DE4238860A1 (en) 1992-11-19 1994-05-26 Medicon Gmbh Skin-protecting agents for protecting human skin
US5616746A (en) * 1993-04-15 1997-04-01 L'oreal Use in cosmetics of lipophilic derivatives of amino deoxyalditols, cosmetic compositions containing them, and novel alkyl carbamates
ZA9406016B (en) * 1993-08-30 1996-02-12 Colgate Palmolice Company An aerosol shaving cream formulation
US5534265A (en) * 1994-08-26 1996-07-09 The Procter & Gamble Company Thickened nonabrasive personal cleansing compositions
US5540853A (en) * 1994-10-20 1996-07-30 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5653970A (en) * 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
US6086903A (en) * 1996-02-26 2000-07-11 The Proctor & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
AU9162498A (en) * 1997-08-18 1999-03-08 Neubourg, Stephanie Foaming skin cream, uses thereof and a method for producing the same

Patent Citations (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2968628A (en) * 1958-10-17 1961-01-17 Shulton Inc Propellant composition
US3666863A (en) * 1968-03-06 1972-05-30 Medisan Ab Skin-treating composition and vehicle for skin-treating agents
US3970584A (en) * 1973-02-14 1976-07-20 S. C. Johnson & Son, Inc. Aerosol package containing a foam-forming emulsion and propellent system
US4145411A (en) * 1974-09-05 1979-03-20 Colgate-Palmolive Company Pressurized foaming shaving composition
US4137302A (en) * 1976-04-02 1979-01-30 Lever Brothers Company Cosmetic composition
US4569839A (en) * 1981-02-27 1986-02-11 L'oreal Cosmetic compositions for the treatment of the hair and skin contain in the form of a powder particles resulting from the pulverization of at least one plant substance and a cohesion agent
US4459285A (en) * 1981-02-27 1984-07-10 Societe Anonyme Dite: L'oreal Cosmetic composition for the treatment of the hair and skin comprising a powder of flowers or flower tops and a cohesion agent
US4661340A (en) * 1983-06-06 1987-04-28 Interkemia Vegyipari Gazdasagi Tarsasag Quail egg based stabilized foam compositions for cosmetic purposes
US5000938A (en) * 1988-08-12 1991-03-19 Innovatec S.A. Protective aerated foam hand lotion and process for preparing the same
US5139781A (en) * 1990-02-13 1992-08-18 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Topical composition comprising mono- and di-alkyl or alkenyl phosphates and alkylamidopropyl betaines of alkylamphoglycinates
US5472686A (en) * 1990-12-28 1995-12-05 Nippon Unicar Company Limited Cosmetic formulations
US5086903A (en) * 1991-04-08 1992-02-11 Interrolll Holding Ag Tandem brake roller system
US5439682A (en) * 1991-11-22 1995-08-08 Richardson-Vicks Inc. Combined personal cleansing and moisturizing compositions
US5278263A (en) * 1992-10-05 1994-01-11 The Goodyear Tire & Rubber Company Syndiotactic 1,2-polybutadiene synthesis in an aqueous medium utilizing N,N-dibutylformamide as a modifier
US5334387A (en) * 1993-02-23 1994-08-02 Colgate-Palmolive Company Topical composition comprising mono and dialkyl phosphates with a cosurfactant
US5902590A (en) * 1994-03-03 1999-05-11 Henkel Kommanditgesellschaft Auf Aktien Cosmetic and/or pharmaceutical formulations
US5621012A (en) * 1994-06-14 1997-04-15 Beiersdorf Aktiengesellschaft Active compound combinations having a content of glyceryl alkyl ethers and cosmetic and dermatological formulations comprising such active compound combinations
US5525588A (en) * 1994-09-14 1996-06-11 Elzabeth Arden Co. Cosmetic composition
US5500211A (en) * 1994-09-22 1996-03-19 The Gillette Company Soap-free self-foaming shave gel composition
US5788972A (en) * 1994-10-24 1998-08-04 L'oreal Product for topical application containing a lipase and an active ingredient precursor
US5674511A (en) * 1994-12-06 1997-10-07 The Procter & Gamble Company Shelf stable skin cleansing liquid with gel forming polymer, lipid and crystalline ethylene glycol fatty acid ester
US5882659A (en) * 1995-12-01 1999-03-16 L'oreal Use of a polyholoside in a cleaning or make-up-removing composition and composition comprising same
USH2013H1 (en) * 1997-05-23 2002-02-05 The Procter & Gamble Company Skin care compositions

Cited By (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20080138293A1 (en) * 2002-10-24 2008-06-12 Foamix Ltd Cosmetic and pharmaceutical foam
US20100284938A1 (en) * 2002-10-25 2010-11-11 Foamix Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20050074414A1 (en) * 2002-10-25 2005-04-07 Foamix Ltd. Penetrating pharmaceutical foam
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20050232869A1 (en) * 2002-10-25 2005-10-20 Foamix Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20050244342A1 (en) * 2002-10-25 2005-11-03 Foamix Ltd. Moisturizing foam containing lanolin
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20050271598A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Body cavity foams
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20060140984A1 (en) * 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US20070020213A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20070020304A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US20070253911A1 (en) * 2002-10-25 2007-11-01 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080044444A1 (en) * 2002-10-25 2008-02-21 Foamix Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US20100040561A9 (en) * 2002-10-25 2010-02-18 Foamix Ltd. Penetrating pharmaceutical foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US20080253973A1 (en) * 2002-10-25 2008-10-16 Foamix Ltd. Sensation modifying topical composition foam
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20090180970A1 (en) * 2002-10-25 2009-07-16 Foamix Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20060269485A1 (en) * 2002-11-29 2006-11-30 Foamix Ltd. Antibiotic kit and composition and uses thereof
US8119106B2 (en) 2003-04-28 2012-02-21 Foamix Ltd Foamable iodine compositions
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US20040265240A1 (en) * 2003-04-28 2004-12-30 Foamix Ltd. Foamable iodine composition
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20100266510A1 (en) * 2003-08-04 2010-10-21 Foamix Ltd. Foamable Vehicle and Pharmaceutical Compositions Thereof
US20050031547A1 (en) * 2003-08-04 2005-02-10 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20110002857A1 (en) * 2003-08-04 2011-01-06 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050069566A1 (en) * 2003-08-04 2005-03-31 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8114385B2 (en) 2003-08-04 2012-02-14 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20070280891A1 (en) * 2003-08-04 2007-12-06 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080299220A1 (en) * 2003-08-04 2008-12-04 Dov Tamarkin Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050075407A1 (en) * 2003-08-25 2005-04-07 Foamix Ltd. Foam incorporating eutetic mixture
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US20080267890A1 (en) * 2005-01-20 2008-10-30 Kayban Pty Ltd. Anti-Microbial Agent
US9078845B2 (en) * 2005-01-20 2015-07-14 Kayban Pty Ltd Anti-microbial agent
US20060275221A1 (en) * 2005-05-09 2006-12-07 Foamix Ltd. Saccharide foamable compositions
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20070098647A1 (en) * 2005-09-28 2007-05-03 Neubourg Skin Care Gmbh & Co. Kg Skin care products
US20080166303A1 (en) * 2006-09-08 2008-07-10 Dov Tamarkin Colored or colorable foamable composition and foam
US20090175799A1 (en) * 2006-09-08 2009-07-09 Dov Tamarkin Colored or colorable topical composition foam
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20110097279A1 (en) * 2006-11-14 2011-04-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20100221195A1 (en) * 2006-11-14 2010-09-02 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US20110212033A1 (en) * 2007-12-07 2011-09-01 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US20100310476A1 (en) * 2007-12-07 2010-12-09 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses

Also Published As

Publication number Publication date
US20030059394A1 (en) 2003-03-27
CA2300054C (en) 2003-09-30
ES2170522T5 (en) 2011-11-14
WO1999008649A2 (en) 1999-02-25
EP1014916A2 (en) 2000-07-05
CA2300054A1 (en) 1999-02-25
US20080213193A1 (en) 2008-09-04
DK1014916T3 (en) 2002-04-15
PT1014916E (en) 2002-06-28
EP1014916B1 (en) 2001-12-19
JP4057234B2 (en) 2008-03-05
DK1014916T4 (en) 2011-09-26
AT210954T (en) 2002-01-15
US20020001599A1 (en) 2002-01-03
JP2001515022A (en) 2001-09-18
US6423323B2 (en) 2002-07-23
WO1999008649A3 (en) 1999-05-14
ES2170522T3 (en) 2002-08-01
EP1014916B2 (en) 2011-06-15
AU9162498A (en) 1999-03-08

Similar Documents

Publication Publication Date Title
EP0793955B1 (en) Pressurised dispensers comprising an ultrafine foaming o/w emulsion
US4883659A (en) Skin treatment preparation
KR950002879B1 (en) Foamed aerosol preparation
CA2776692C (en) Penetrating pharmaceutical foam
CN1149069C (en) Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant
AU624110B2 (en) Skin conditioning composition
CA2274565C (en) Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
US8119109B2 (en) Foamable compositions, kits and methods for hyperhidrosis
US7700076B2 (en) Penetrating pharmaceutical foam
KR100332259B1 (en) Stable W/O/W emulsion and its use as cosmetic and/or dermatological composition
US4563346A (en) Topical delivery system and skin treatment compositions employing such system
EP0058853B1 (en) Skin care composition
US20080031907A1 (en) Cosmetic and pharmaceutical foam
US5336692A (en) Ointment base and method of use
DE60122879T2 (en) Sprayable skin protection products
AU2005285441B2 (en) Pharmaceutically elegant, topical anhydrous aerosol foam
EP1108421A2 (en) Multilayered foaming spray product
CA2502986C (en) Cosmetic and pharmaceutical foam
US20050069566A1 (en) Foam carrier containing amphiphilic copolymeric gelling agent
US4970220A (en) Skin conditioning composition
US4335104A (en) Anhydrous multi-purpose moisturizing composition
US4355046A (en) Dermatologic and cosmetic ointment base
ES2532906T3 (en) cosmetic and pharmaceutical foam
US4478853A (en) Skin conditioning composition
US4545990A (en) Anti-acne composition

Legal Events

Date Code Title Description
AS Assignment

Owner name: NEUBOURG SKIN CARE GMBH & CO. KG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NEUBOURG, STEPHANIE;REEL/FRAME:019161/0303

Effective date: 20070320

AS Assignment

Owner name: NEUBOURG SKIN CARE GMBH & CO. KG, GERMANY

Free format text: CORRECTIVE ASSIGNMENT TO CHANGE "ISSUED PATENT NUMBER" UNDER SECTION 4 FROM "6423434" TO -6423323--(PREVIOUSLY RECORDED AT R/F 019161/0303);ASSIGNOR:NEUBOURG, STEPHANIE;REEL/FRAME:019254/0492

Effective date: 20070320

Owner name: NEUBOURG SKIN CARE GMBH & CO. KG, GERMANY

Free format text: CORRECTIV;ASSIGNOR:NEUBOURG, STEPHANIE;REEL/FRAME:019254/0492

Effective date: 20070320

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION